The Friedman Brain Institute
Press Releases
- Largest Brain Autopsy Study of Female Intimate Partner Violence Decedents Reveals Brain Injury Pathology Unlike That Seen Among Male Contact Sports Athletes — October 30, 2023
- Dysregulation of the Brain’s Reward Learning System Is Identified by Scientists as a Potential Driver and Treatment Target for Cocaine Addiction — October 25, 2023
- Researchers Construct First “Multiome”Atlas of Cell Development in the Human Cerebral Cortex From Before Birth to Adulthood — October 12, 2023
- Cellular Atlas of a Human Brain Language Area Is Constructed by a Team of International Scientists — October 12, 2023
- Mount Sinai Researchers First to Develop Age Prediction Model on Human Brain Tissue Using Artificial Intelligence — October 10, 2023
- Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression — September 20, 2023
- Mount Sinai Participates in $40 Million Multisite Study of Alzheimer’s Disease in Asian Americans and Asian Canadians — July 13, 2023
- Mount Sinai Alzheimer’s Researcher Is the First Woman to Win Prize From Prestigious German Research Institute — July 12, 2023
- New Research Reveals the Men Die of Overdose at Two-to-Three Times Greater a Rate Than Women in the United States — June 15, 2023
- A Key Biological Pathway for Multiple Sclerosis Is Uncovered by Mount Sinai Researchers — May 8, 2023
- NYC Mayor Eric Adams Joined Top Biomedical Researchers to Usher in the Center for Engineering and Precision Medicine at Hudson Research Center at 619 West 54th Street — March 30, 2023
- Researchers Identify Novel Genes That May Increase Risk For Schizophrenia — March 13, 2023
- New Scientific Evidence Emerges on How Individuals Transition From Recreational to Compulsive Use of Drugs — March 07, 2023
- Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children — March 02, 2023
- Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans — February 10, 2023
- Mount Sinai Launches Neurometabolomics and Neuroinformatics Core to Combat Rare Brain Diseases — February 02, 2023
- Exposure to World Trade Center Dust Exacerbates Cognitive Impairment in an Animal Model of Alzheimer’s — January 17, 2023
- Mount Sinai Scientists Awarded Grant from Chan Zuckerberg Initiative to Advance Understanding and Therapeutics for Rare Blood Vessel Disease — December 01, 2022
- Heightened Activity of Specific Brain Cells Following Traumatic Social Experience Blocks Social Reward and Promotes Sustained Social Avoidance — November 30, 2022
- Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain — November 30, 2022
- Mount Sinai and MIT Researchers Uncover Link Between a Key Gene for Alzheimer’s Disease and Cholesterol Build-Up in the Brain — November 16, 2022
- Ian Maze, PhD, Named 2022 Recipient of Jacob P. Waletzky Award by Society for Neuroscience — November 14, 2022
- Study Explores Sex Differences in the Effects of SARS-CoV-2 in Young Adults — November 09, 2022
- Sites in the Brain Where RNA Is Edited Could Help to Better Understand Neurodevelopment and Disease, Researchers Have Found — November 01, 2022
- Stem Cell Study Reveals How Neurons From PTSD Patients React to Stress — October 20, 2022
- Brain’s Sensitivity to Different Types of Regret May Impact Mood Disorders Like Depression, Mount Sinai Researchers Find — October 19, 2022
- Human Cocaine and Heroin Addiction Is Found Tied to Impairments in Specific Brain Circuit Initially Implicated in Animals — October 06, 2022
- Mount Sinai Receives $2 Million From the Parkinson’s Foundation to Investigate Underlying Cell-Specific Mechanisms of the Condition — October 03, 2022
- Brain Injury Research Center at Mount Sinai Awarded $8.3 Million from the National Institutes of Health to Investigate Post-Traumatic Brain Injury Neurodegeneration — September 29, 2022
- New Research Shows Children Exposed to Natural Disasters in the Womb Have Higher Rates of Developmental Psychopathology in a Sex-Specific Manner — September 21, 2022
- Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research Announces their Inaugural Postgraduate Research Fellows — September 08, 2022
- New Study Suggests Ketamine May Be An Effective Treatment for Children with ADNP Syndrome — September 06, 2022
- Study of More Than 150,000 People Identifies Genes Strongly Linked to Autism and Neurodevelopmental Disorders — August 17, 2022
- Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center — August 12, 2022
- A Stem Cell Model From Mount Sinai Could Help Unravel the Complex Biology Behind Some Psychiatric Disorders — June 1, 2022
- Mount Sinai Leads Multi-Site Study Evaluating a Novel Intervention Designed to Improve Community Re-Entry Outcomes for Justice-Involved Individuals With Brain Injuries — May 31, 2022
- Two Leading Mount Sinai Brain Scientists Elected to the National Academy of Sciences — May 5, 2022
- Late-Onset Alcohol Abuse Can Be a Presenting Symptom of Dementia, Researchers Find — April 4, 2022
- Stability in Body Mass Index Over Time Is Associated With a Better Cognitive Trajectory in Older Adults — January 20, 2022
- Can a Human Microglial Atlas Guide Brain Disorder Research? — January 6, 2022
- Ten Medical and Scientific Breakthroughs of 2021 at Mount Sinai — December 28, 2021
- Mount Sinai Researchers Uncover a Key Neural Mechanism Believed to Support Advanced Cognitive Abilities — December 21, 2021
- Kenneth L. Davis, MD, CEO of Mount Sinai Health System, Recognized as One of the “100 Most Influential People” by Modern Healthcare — December 20, 2021
- Mount Sinai Expands Resilience Program Created for Front-Line Health Care Workers to the Larger Community Through Faith-Based Organizations in Neighborhoods Hit Hardest by COVID-19 — December 16, 2021
- Mount Sinai Alzheimer’s Researcher Wins Rainwater Prize for Outstanding Innovation in Neurodegenerative Research — December 14, 2021
- Researchers Discover How Cells From Tumors Remain Dormant for Years Before Metastasis Occurs — December 13, 2021
- Icahn School of Medicine at Mount Sinai Announces New Biomedical Laureates as Part of Drive to Diversify Research — December 13, 2021
- Mount Sinai Joins the Glioma Connectome Project, a Newly Established Consortium of Leading Neurosurgery Centers Dedicated to Advancing Brain Cancer Research and Treatment — November 30, 2021
- Largest Genetic Study of Suicide Attempts Confirms Genetic Underpinnings That Are Not Driven by Underlying Psychiatric Disorders — November 29, 2021
- Allen Institute Appoints Mount Sinai Neuroscientist as a Next Generation Leader — November 16, 2021
- Cannabis Use During Pregnancy Impacts the Placenta and May Affect Subsequent Child Development — November 15, 2021
- The Brain Changes Its Rhythm Within Minutes of Therapeutic Stimulation During Deep Brain Stimulation Surgery for Treatment-Resistant Depression — November 02, 2021
- Mount Sinai Launches the Brain and Body Research Center, Among the First in the U.S.to Focus Solely on How the Brain and Body Interact — October 18, 2021
- Mount Sinai Neurobiologist Selected as a Howard Hughes Medical Institute Investigator — September 23, 2021
- Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research Receives $5 Million Grant From The Bob & Renee Parsons Foundation — September 09, 2021
- Old Habit-Controlling Neurons May Also Help the Brain Learn New Tricks — August 25, 2021
- Mount Sinai Partners With Studio Elsewhere to Launch Q-Lab, an Immersive, Interactive Research and Restorative Care Environment for Deep Brain Stimulation Patients — August 11, 2021
- Mount Sinai Mobile Interventional Stroke Team Travels to Patients, Resulting in Faster Treatment and Better Outcomes — August 4, 2021
- Study Shows Visual Evoked Potential Is a Promising Tool for Translational Research Into Phelan-McDermid Syndrome and Autism Spectrum Disorders — July 29, 2021
- Mount Sinai’s J Mocco, MD, to Lead the Society of NeuroInterventional Surgery — July 29, 2021
- Mount Sinai scientists discover early signs of frontotemporal dementia in personalized cerebral organoids — July 26, 2021
- Outstanding Mount Sinai Doctoral Student Receives a Howard Hughes Medical Institute Gilliam Fellowship to Support Diversity and Inclusion in Science — July 22, 2021
- The Steven & Alexandra Cohen Foundation Grants More than $2.1 Million to Support a Psychedelics Research Study at Mount Sinai — July 09, 2021
- Mount Sinai’s Kalmon D. Post, MD, to Lead The Pituitary Society — July 07, 2021
- Largest Genetic Study of Bipolar Disorder Identifies 64 Regions of the Genome That Increase Risk for the Condition — May 13, 2021
- Mount Sinai Scientists Discover an Epigenetic Mechanism Contributing to Lifelong Stress Susceptibility — March 15, 2021
- Researchers Identify Brain Ion Channel as New Approach to Treating Depression — March 03, 2021
- Mount Sinai Researchers Uncover a Neural Pathway that is Critical to Correcting Behavioral Errors Relevant to Many Psychiatric Disorders — February 19, 2021
- Mount Sinai Researchers Identify and Characterize Three Molecular Subtypes of Alzheimer’s Disease — January 06, 2021
- Mount Sinai Health System Launches Center for Psychedelic Research — January 07, 2021
- Mount Sinai and Rumi Scientific Team Up to Advance Drug Discovery for Rare Genetic Disorders Tied to Autism — January 06, 2021
- Repeated Ketamine Infusions Reduce Symptom Severity in Individuals With Chronic Post-Traumatic Stress Disorder — January 05, 2021
- In COVID-19-Positive Stroke Patients, More Severe Strokes and Worse Outcomes Than in COVID-19-Negative Patients — December 07, 2020
- Two Mount Sinai Neuroscientists Receive Prestigious Awards From the Society for Neuroscience — October 28, 2020
- The Novel Role of Microglia as Modulators of Neurons in the Brain Is Discovered by Mount Sinai Researchers — September 30, 2020
- Researchers Discover a Specific Brain Circuit Damaged by Social Isolation During Childhood — August 31, 2020
- Elevated Level of a “Hunger” Hormone Leaves Trauma-Exposed Adolescents at Higher Risk of Developing Post-Traumatic Stress Disorder — August 20, 2020
- Mount Sinai Researchers Identify Protein that Protects Against Alzheimer’s Disease — August 17, 2020
- Epigenetic Changes in ADNP Syndrome, a Cause of Autism, Do Not Indicate Profound Presentation of the Disorder — August 05, 2020
- Seaver Autism Center For Research and Treatment at Mount Sinai Launches First Drug Trial for ADNP Syndrome — July 07, 2020
- Mount Sinai Researchers Discover a Novel Role for Dopamine That Impacts Gene Expression Related to Cocaine Abuse — April 09, 2020
- Researchers Identify a Protein That Is Critical for Wound Healing after a Central Nervous System Injury — March 02, 2020
- Brain Scan-Blood Test Panel Promises Improved Diagnosis of Brain Trauma Following Battlefield Blast Exposure — February 25, 2020
- Mount Sinai to Accelerate Rare Disease Research Through a Grant from the Chan Zuckerberg Initiative — February 10, 2020
- Helping Patients With Binge Eating Disorders: There’s an App for That — February 03, 2020
- Largest Autism Sequencing Study to Date Identifies 102 Genes Associated With the Condition — January 23, 2020
- Mount Sinai Scientist Recognized for Outstanding Basic Research Contributions to Neuropsychopharmacology — December 9, 2019
- Alcohol Byproduct Contributes to Brain Chemistry Changes in Reward Learning and Memory Centers — October 23, 2019
- Smoke Signals - Study Shows Path Linking Nicotine Addiction to Increased Risk for Diabetes — October 16, 2019
- Mount Sinai Researchers Identify Brain Protein That Promotes Maintenance of Chronic Pain — October 16, 2019
- Long-Term Follow-Up Data Shows Deep Brain Stimulation Is an Effective Treatment for Treatment-Resistant Depression — October 4, 2019
- The Propensity to Hear “Voices” in Schizophrenia May Be Established by Infancy, Many Years Before Symptom Onset — October 2, 2019
- NIH New Innovator Award Will Advance Brain Science — October 1, 2019
- Icahn School of Medicine at Mount Sinai Receives Multiple Grants from the National Institutes of Health to Help Conquer the Opioid Crisis — September 27, 2019
- Philanthropic Gift to Mount Sinai Establishes The Lipschultz Center for Cognitive Neuroscience — September 3, 2019
- Individuals Who Attempt Suicide Carry an Increased Genetic Liability for Depression, Regardless of Their Psychiatric Disorder — June 5, 2019
- CBD Reduces Craving and Anxiety in People With Heroin Use Disorder — May 21, 2019
- The Icahn School of Medicine at Mount Sinai Renames Department of Neuroscience in Honor of The Nash Family — May 09, 2019
- Could Taking a Drug Within a Few Hours of a Trauma Help Avert Post Traumatic Stress Disorder? — April 25, 2019
- Short Period of Parental Sexual Contact Prior to Pregnancy Increases Offspring Risk of Schizophrenia — April 23, 2019
- Icahn School of Medicine at Mount Sinai Receives $1 Million as an Inaugural Recipient of NYFIRST Medical School Grant From New York State — April 09, 2019
- Philanthropic Gift to Mount Sinai Establishes The Nash Family Center for Advanced Circuit Therapeutics — March 26, 2019
- Mount Sinai Study Suggests Vitamin B12 May Be Potential Antidote to LRRK2-Associated Parkinson’s Disease — March 20, 2019
- Mount Sinai Neuroscience Researchers Discover Surprise Role for Serotonin - The Brain Chemical Can Directly Regulate Gene Expression Inside Brain Cells — March 13, 2019
- Mount Sinai Researchers Lead Trial Showing Aspiration Is Equally Effective as, and Significantly Cheaper Than, Traditional Stent Retriever Approach for Clot Removal — March 7, 2019
- Two Mount Sinai Neuroscientists Named 2019 Sloan Research Fellows — March 1, 2019
- Mount Sinai Neuroscience Department Ranked No. 1 in Nation in NIH Funding — February 20, 2019
- Meta-Analysis Highlights Important Challenges In Cognitive Processing For Adults With Autism Spectrum Disorder Without Overall Intellectual Disability — January 2, 2019
- Paul Kenny, PhD, Recognized for Outstanding Basic Research Contributions to Neuropsychopharmacology — December 13, 2018
- Four Studies by Mount Sinai Investigators Featured in Upcoming Special Issue of Science Focused on Big Data — December 13, 2018
- New Research Suggests Your Imagination Really Can Set You Free From Fear — November 21, 2018
- Common Medications Taken During Pregnancy Are Not Associated With Risk for Autism — October 31, 2018
- The Addiction Institute of Mount Sinai and Center on Addiction Forge Strategic Alliance to Improve Addiction Treatment — October 12, 2018
- Previously unknown genetic aberrations found to be associated with Alzheimer’s progression — October 8, 2018
- Scientists Look Directly Inside Tumor Cells of Glioblastoma Patients to Uncover Specific Protein as an Important Regulator of Tumor Migration — October 1, 2018
- Gut Branches of the Vagus Nerve Are Essential Components of the Brain’s Reward and Motivation System — September 20, 2018
- Mount Sinai Scientist Receives Inaugural Landis Award for Outstanding Mentorship — September 18, 2018
- The Icahn School of Medicine at Mount Sinai Joins NeuroNEXT Research Network Through Five-Year Grant From the National Institutes of Health — August 2, 2018
- Mount Sinai Study Provides Insight Into How Dying Neurons Control “Eating” Behaviors of the Brain’s Debris Clearing Cells — July 23, 2018
- Mount Sinai Studies Selected as Top Research Advances of 2017 by Federal Advisory Committee on Autism — July 05, 2018
- Mount Sinai Neuroscientist Chosen as 2018 Pew Scholar by Pew Charitable Trusts — June 19, 2018
- Mount Sinai Health System Hospitals Receive Get With The Guidelines®-Stroke Gold Plus Quality Achievement Awards — June 7, 2018
- Human Drug Addiction Behaviors Closely Tied to Specific Impairments Within Six Large-Scale Brain Networks — June 6, 2018
- The Seaver Autism Center for Research and Treatment at Mount Sinai Announces Clinical Trial of New Investigational Therapy for Phelan-McDermid Syndrome — May 7, 2018
- Mount Sinai of New York and Els for Autism Foundation Join Forces to Establish Research Institute at The Els Center of Excellence in Jupiter, Florida — April 2, 2018
- The Seaver Center for Autism Research and Treatment Receives $2.78 Million Gift from the Beatrice and Samuel Seaver Foundation to Support Precision Medicine Research in Autism Spectrum Disorders — March 05, 2018
- Mount Sinai Researchers Find Grape-Derived Compounds Capable of Promoting Resilience Against Stress-Induced Depression — February 02, 2018
- Helen S. Mayberg, MD, Appointed Director of Newly Established Center for Advanced Circuit Therapeutics for the Icahn School of Medicine at Mount Sinai — January 8, 2018
- Mount Sinai Study to Characterize Rare Neurodevelopmental Disorder Tied to Autism — December 12, 2017
- Mount Sinai Neuroscientist Awarded Two Prestigious Honors — December 7, 2017
- Icahn School of Medicine at Mount Sinai and Unyts Collaborate to Increase Brain Tissue Donation for Autism Research — September 12, 2017
- Two Distinct Brain Regions Have Independent Influence on Decision-Making — August 30, 2017
- Mount Sinai Scientists Find DNA Folding Patterns May Be Related to Neurological Disorders — July 3, 2017
- The Icahn School of Medicine at Mount Sinai and The Advanced Science Research Center at the Graduate Center of the City University of New York Launch Inter-Institutional Glial Biology Initiative — June 27, 2017
- Risk of Developing Alzheimer’s Disease Linked to a Network of Genes Associated With Myeloid Cells — June 26, 2017
- New Research Suggests Older Dads Have “Geekier” Sons — June 20, 2017
- Early Stress Exposure Confers Lifelong Vulnerability, Causing Long-Lasting Alterations in a Specific Brain Reward Region — June 15, 2017
- Exposure to Specific Toxins and Nutrients During Late Pregnancy and Early Life Correlated With Autism Risk — June 1, 2017
- Mount Sinai Study Reveals How Learning in the Present Shapes Future Learning — April 6, 2017
- Mount Sinai Researchers Receive Major NIH Award for Autism Genetics Research — April 3, 2017
- Epigenetic Alteration a Promising New Drug Target for Heroin Use Disorder — March 22, 2017
- All in the Family: New Research Explains How Family Members Can Impact an Autism Diagnosis — March 15, 2017
- Some Genetic Variations May Be Particularly Difficult To Evaluate Using Current Stem Cell Modeling Techniques — March 13, 2017
- The Brain Injury Research Center at Mount Sinai Appoints New Director — February 2, 2017
- Mount Sinai Neurobiologist Illuminates the Underexplored Potential of Cannabis to Address Opioid Addiction — February 2, 2017
- Mount Sinai Researchers Generate First In-Depth Characterization of a Genetically Modified Rat Model for Autism and Intellectual Disability — January 30 , 2017
- Key Signaling Protein Associated with Addiction Controls the Actions of Oxycodone in Pain-Free and Chronic Pain States — January 17, 2017
- Researchers Reveal Connection Between Female Estrogen Cycle and Addictive Potential of Cocaine — January 10, 2017
- Using Teeth to Reconstruct how the Brain Develops — December 27, 2016
-
Mount Sinai Researchers Receive $15.5 Million Grant to Map Molecular Changes That Occur During Physical Activity — December 15, 2016
-
Eric J. Nestler, MD, PhD, Assumes Role as President of the Society for Neuroscience During 2016 Annual Meeting — November 16, 2016
- Icahn School of Medicine at Mount Sinai Receives Award From United States Department of Defense For Innovative Treatment of Veterans with Gulf War Illness — November 10, 2016
- Two Mount Sinai Researchers Elected to National Academy of Medicine — October 26, 2016
- Mount Sinai Researcher Awarded 2016 BRAIN Initiative Grant — October 14, 2016
- Experimental Imaging Agent Reveals Concussion-Linked Brain Disease in Living Brain — September 27, 2016
- Mount Sinai Begins Recruitment for Landmark Study of Adolescent Brain Development — September 13, 2016
- Defect In Process That Controls Gene Expression May Contribute To Huntington’s Disease And Other Neurodegenerative Disorders - August 15, 2016
- Specialized Nerve Cells in Brain Region Responsible for Emotional Memory Play Important Role in Fear Learning - July 14, 2016
- Motivation to Bully is Regulated by Brain Reward Circuits - June 29, 2016
- Study Suggests Depression is Driven by Networks of Genes That Span Brain Circuits — May 12, 2016
- Enzyme Dnmt1 in Developmental Myelination Process Could Lead to Better Understanding of Neurological Disorders — April 14, 2016
- Mount Sinai Chosen for 2017-2019 Edmond J. Safra Fellowship in Movement Disorders — March 28, 2016
- Mount Sinai Participates in Landmark Study to Investigate Substance Use and Adolescent Brain Development - November 2, 2015
- Joseph D Buxbaum PhD Elected to National Academy of Medicine - October 19, 2015
- Suppression of Epigenetic Brain Proteins Induces Autism-Like Syndrome - October 8, 2015
- Mount Sinai Study Finds Emotional Behavior Altered After Multiple Exposures to Anesthesia During Infancy - September 3, 2015
- Antidepressants Fine-tune Brain Reward Pathway to Lessen Neuropathic Pain - August 24, 2015
- Mount Sinai Alzheimers Disease Expert Receives Lifetime Achievement Award - August 5, 2015
- Eric J. Nestler, MD, PhD, to Lead Society for Neuroscience - July 23, 2015
- Mount Sinai Researchers Identify Genetic Markers Linking Risk for Both Type 2 Diabetes and Alzheimer’s Disease - July 16, 2015
- Human Brain May Contain a Map for Social Navigation - July 1, 2015
Study reveals how the hippocampus contributes to social behavior - New Compounds Protect Nervous System From the Structural Damage Characteristic of Multiple Sclerosis - February 27, 2015
Pharmacological Agents Hold Promise for Several Neurodegenerative Disorders - $2.5 Million NIH Grant to Fund Mount Sinai Research into Reducing Heroin Injection and HIV Infection - February 23, 2015
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), has awarded Don C. Des Jarlais, PhD, a 2015 Avant-Garde Award. - Mount Sinai Health System Names Director of Newly Established Ronald M. Loeb Center for Alzheimer’s Disease - February 19, 2015
Renowned neuropsychiatric researcher Alison Goate, PhD, has joined the Mount Sinai Health System as the founding Director of the Ronald M. Loeb Center for Alzheimer’s Disease. - Growth Hormone Treatment Improves Social Impairments in Patients with Genetic Disorder Known to Cause Autism - February 18, 2015
A growth hormone can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome. - Cocaine Users Have Impaired Ability to Predict Loss - February 4, 2015
- Gift to Mount Sinai Health System Establishes Ronald M. Loeb Center for Alzheimer’s Disease - December 16, 2014
$15 Million Gift By Daniel and Margaret Loeb in Memory of Ronald M. Loeb; Center Dedicated to Alzheimer’s Disease Research - The Mount Sinai Health System Names New Vice Chair of Neurosurgery and Director of the Cerebrovascular Surgery Program - December 4, 2014
- Behavioral Flexibility Impaired After Exposure to Oxycodone - November 17, 2014
Study reveals new mechanisms related to addiction - Brain Protein Influences How the Brain Manages Stress; Suggests New Model of Depression - November 12, 2014
Discovery of new molecular and behavioural connections may provide a foundation for the development of new treatments to combat some forms of depression - Changes in a Single Gene’s Action Can Control Addiction- and Depression-Related Behaviors - November 10, 2014
New DNA regulatory technique modifies the environment around a single gene to control gene expression and behavioral consequences - Changes in Scores of Genes Contribute to Autism Risk - October 29, 2014
Newfound Genetic Differences Provide Many Hints at Causes - Stress-Related Inflammation May Increase Risk for Depression - October 20, 2014
- Mount Sinai a Lead Site in NIH-Funded Rare Diseases Consortium Studying Autism and Intellectual Disability - October 15, 2014
10-institution study seeks to pilot new treatment approaches - Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain - September 16, 2014
Detection while patient is still alive improves accuracy of diagnosis and enables estimation of prevalence and risk - New Study Examines Impact of Violent Media on the Brain - September 10, 2014
Exposure to violence has a different effect on people with aggressive traits - Common Gene Variants Account for Most of the Genetic Risk for Autism - July 21, 2014
Heritability trumps spontaneous glitches, environment - Cocoa Extract May Counter Specific Mechanisms of Alzheimer’s Disease - June 23, 2014
Insights into mechanisms behind cocoa’s benefit may lead to new treatments or dietary regimens - Lawrence C. Newman, MD, of Mount Sinai Roosevelt Elected New President of The American Headache Society - June 4, 2014
Neurologist is Also Director of The Headache Institute at Mount Sinai Roosevelt - Icahn School of Medicine at Mount Sinai Joins Autism BrainNet Tissue Bank - May 29, 2014
Consortium of premiere research institutions will provide critically needed brain tissue for autism research - Mount Sinai Researchers Lead International Advisory Committee To Define The Clinical Course of Multiple Sclerosis - May 28, 2014
Re-examination of standardized multiple sclerosis descriptions published in 1996 to influence future research studies and clinical practice - Mount Sinai Researchers Identify Subtle Changes that May Occur in Neural Circuits Due to Cocaine Addiction - May 7, 2014
Research May Offer a Unique Pathway for Targeting New Therapeutics for Addiction Treatment - Genetic and Environmental Influences Are Equally Important Risk Factors for Autism Spectrum Disorder - May 5, 2014
- Mount Sinai Researchers Identify Genetic Alterations in Shared Biological Pathways as Major Risk Factor for Autism Spectrum Disorder - April 24, 2014
A substantial proportion of risk for developing autism spectrum disorders (ASD), resides in genes that are part of specific, interconnected biological pathways, according to researchers from the Icahn School of Medicine at Mount Sinai. - Intravenously Administered Ketamine Shown to Reduce Symptoms of Chronic Post-Traumatic Stress Disorder - April 16, 2014
Researchers from Mount Sinai demonstrate proof of concept for new, rapidly-acting pharmacotherapy for treatment of PTSD. - Intranasal Ketamine Confers Rapid Antidepressant Effect in Depression - April 8, 2014
Mount Sinai team cautiously optimistic that door could swing open to a new antidepressant drug class. - Susan B. Bressman, MD, Honored as "National Physician of the Year" By Castle Connolly Medical, Ltd., Publisher of the Annual America's Top Doctors® Guides - April 1, 2014
Dr. Bressman was recognized at the Ninth Annual Castle Connolly Medical Ltd. National Physician of the Year Awards on March 31. - Avoiding Harmful Byproducts of Heat-Processed Foods Protects Against Risk of Alzheimer’s Disease and Diabetes - February 24, 2014
Modifying dietary intake of Advanced Glycation Endproducts, or AGEs, bolsters body’s defenses against Alzheimer’s and Metabolic Syndrome. - Opioid Abuse Initiates Specific Protein Interactions in Neurons in Brain’s Reward System - February 24, 2014
RGS9-2 protein affects not only addiction, but analgesic relief and tolerance. - With Large-Scale New Studies, Mount Sinai Scientists Help Underscore the Genetic Complexity in Schizophrenia - January 22, 2014
Largest exome studies of schizophrenia to date establish critical new scientific resources for biomedical community and the possibility of more tailored treatment for patients. - Novel Nanotherapy Breakthrough May Help Reduce Recurrent Heart Attacks and Stroke - January 20, 2014
Icahn School of Medicine at Mount Sinai designs HDL nanoparticle to deliver statin medication inside inflamed blood vessels to prevent repeat heart attacks and stroke. - Icahn School of Medicine at Mount Sinai Named to New NIH Stroke Research Network - December 20, 2013
Research collaborative network aims to expedite stroke clinical trials, build greater expertise in stroke. - Four Researchers from Icahn School of Medicine at Mount Sinai Among the 400 Most Highly Influential Biomedical Researchers in the World - November 25, 2013
Powerful researchers include Dr. Dennis S. Charney, Dr. Carlos Cordon-Cardo, Dr. Valentin Fuster, and Dr. Eric J. Nestler. - Mount Sinai Researchers Identify Molecular Changes in the Brain that May Increase Risk for Multiple Sclerosis - November 25, 2013
First genome-wide study in brain tissue from MS patients. - Society for Neuroscience Honors Rita Z. Goldstein, PhD, with the Jacob P. Waletzky Award - November 1, 2013
Mount Sinai Researcher Honored for Translational Addiction Research - Two Mount Sinai Physicians Elected to the Institute of Medicine - October 24, 2013
Diane E. Meier, MD and Pamela Sklar, MD, PhD, recognized for Outstanding Professional Achievement and Commitment to Service. - Perception of marijuana as a "safe drug" is scientifically inaccurate - August 27, 2013
The nature of the teenage brain makes users of cannabis particularly at risk of developing addictive behaviors. - Mount Sinai Researchers Publish New Edition of Psychiatry "Bible" - August 7, 2013
In light of the accelerated pace of discovery in understanding psychiatric illnesses, experts from Mount Sinai have published the 4th edition of Neurobiology of Mental Illness. - ADHD Drug Shows Promise in Treating Addiction - June 26, 2013
A single dose of a commonly-prescribed attention deficit hyperactivity disorder drug helps improve brain function in cocaine addiction. - Brain Development in Chimpanzees Provides Insight into the Evolution of the Human Brain - June 13, 2013
The development of brain regions crucial to learning occurred before apes evolved into humans. - Mount Sinai Researchers Provide the First Comprehensive and Prospective Characterization of a Genetic Subtype of Autism - June 11, 2013
First study to describe clinical presentation of Phelan-McDermid Syndrome will help guide future research and clinical care - Pioneering Study Demonstrates Benefit of Imaging Technique in Identifying Mental Illness - June 5, 2013
MRI may be an effective way to diagnose mental illnesses such as bipolar disorder, according to experts from the Icahn School of Medicine at Mount Sinai. - Mount Sinai Researchers Identify New Drug Target for Depression and Neuropathic Pain - April 29, 2013
Increased levels of brain protein in response to antidepressants may lead to new therapies - Mount Sinai Researchers Identify Promising Drug Target for Depression - February 17, 2013
Decreased expression of a protein called Rac1 may be a primary cause of depression, according to a new study in human and mouse brains. - Facts about How Mount Sinai is Researching and Treating Brain Diseases - December 14, 2012
The Mount Sinai Medical Center is one of the world’s leading institutions in discovering better ways to prevent, diagnose, and treat serious brain diseases. - Short DNA Strands in the Genome May be Key to Understanding Human Cognition and Diseases - November 20, 2012
Previously discarded, human-specific “junk” DNA represents untapped resource in the study of diseases like Alzheimer’s and autism - Changes in Nerve Cells Caused by Social Isolation May Contribute to the Development of Mental Illness - November 11, 2012
Reduced production of myelin, a type of nerve fiber that is lost in diseases like MS, may also play a role in the development of mental illness. - Mount Sinai Researchers Unveil New Targets for Depression at Neuroscience 2012 - October 15, 2012
Scientists presented important discoveries on the involvement of the immune system and dopamine on the onset of depression. - Mount Sinai Researchers Find Brain Mechanism Behind Opioid Addiction - October 5, 2012
Chronic morphine exposure has the opposite effect on the brain compared to cocaine in mice, providing new insight into the basis of opiate addiction - Mount Sinai Researcher Receives Prestigious National Institutes of Health Award - September 13, 2012
Anne Schaefer, MD, PhD, Assistant Professor of Neuroscience and Psychiatry, has been recognized with the Director's New Innovator Award. - Researchers Identify Area Of The Brain That Processes Empathy - September 1, 2012
An international team led by Mount Sinai School of Medicine has shown that one area of the brain is the only activity center of empathy. - Researchers Rediscover Potential of Rejected Alzheimer’s Drug to Arrest Progression of Disease in Mice - August 8, 2012
Study Suggests that Latrepirdine, Which Previously Failed in Clinical Trials, May Be Successful if Tested on Patients with Earlier Stages of the Disease - Wayne Goodman, MD, Receives Career Achievement Award from International OCD Foundation - July 28, 2012
The honor was presented to Dr. Goodman at the 19th Annual International OCD Foundation Conference in Chicago. - Mount Sinai Performs First Imaging Test to Detect Alzheimer's Disease in the Clinical Setting - June 20, 2012
The new technique is expected to play a critical role in Alzheimer's disease diagnosis and in research leading to a cure. - Mount Sinai Researcher Receives Career-Starter Research Grant for 2012-2013 - June 20, 2012
Hirofumi Morishita, MD, PhD, receives a Career-Starter Research Grant for 2012-2013 from the Knights Templar Eye Foundation. - Gene that Causes Type 2 Diabetes May Also Cause Alzheimer’s - July 18, 2011
Researchers have found that a gene that causes diabetes kills nerve cells in the brain, possibly resulting in Alzheimer’s disease. - A Natural Chemical Found in Grape Seeds May Prevent Development or Progression of Alzheimer’s - July 15, 2011
Mount Sinai researchers found that polyphenols, a natural extract found in grapes, may help prevent or treat Alzheimer’s disease. - Mount Sinai Celebrates the “Topping Off” of the New Center for Science and Medicine Building - February 7, 2011
Set to open in 2012, CSM will bring nearly a half-million square-feet of new, state-of-the-art medical research and clinical facilities to Mount Sinai. - Mount Sinai Researchers Find That Little-Studied Gene May Boost Long-Term Memory and Enhance Cognition - January 26, 2011
Treatment with a gene called IGF-II significantly improved long-term memory. When the gene was blocked, long-term memories could not form. - Mount Sinai Researchers Make Groundbreaking Discovery on Origin of Brain’s Immune Cells - October 21, 2010
New study could lead to new treatments for degenerative brain diseases, such as Alzheimer’s, and autoimmune disorders, such as multiple sclerosis. - Mount Sinai Researcher Awarded Renowned Institute of Medicine Prize for Outstanding Achievements in Improving Mental Health - October 11, 2010
Dr. Eric Nestler honored for his work and achievements in addiction science. - Antihypertensive Drugs May Protect against Alzheimer’s Disease and Promote Healthy Memory - June 24, 2010
Researchers at Mount Sinai School of Medicine have found that a blood pressure drug may lessen the impact of Alzheimer’s disease and promote healthy memory. - New Autism Susceptibility Genes Identified; Autism Genome Project Phase 2 Results Published in Nature - June 9, 2010
In collaboration with the Autism Genome Project, Mount Sinai has published phase 2 data on gene variants that may lead to new autism treatments. - Mount Sinai Researchers Identify First Drug to Demonstrate Effect in an Animal Model of a Type of Autism - May 20, 2010
Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of an autism subtype. - Wayne K. Goodman, MD, Honored with Mysell Lecture By Harvard Medical School - March 24, 2010
Wayne K. Goodman, MD, Chair of the Department of Psychiatry at Mount Sinai, has been selected to deliver the prestigious Mysell Lecture at Harvard. - New Mount Sinai Support Groups Will Address the Needs of Parkinson's and Dystonia Patients and Their Caregivers - January 5, 2010
Mount Sinai launches four new support groups to assist patients with Parkinson's disease and dystonia. Topics of discussion will include nutrition, new therapies, and caregiver needs. - Mount Sinai Researcher Led Study to Determine If Drug Slows Progression of Parkinson's Disease - September 24, 2009
C. Warren Olanow, MD, Professor and Chairman Emeritus, Department of Neurology, led an 18-month study on whether a drug used to treat Parkinson's actually slows disease progression. - Mount Sinai Research Identifies Brain Mechanisms Associated with Borderline Personality Disorder - September 3, 2009
Through real-time imaging, researchers have collected evidence to suggest that neurological networks that help regulate emotion do not activate in patients with borderline personality disorder. - Mount Sinai Finds Differences in Brain Scans of Patients with Borderline Personality Disorder - March 5, 2009
New research conducted by Mount Sinai physicians suggests that the brain activity of people with borderline personality disorder is different from that of people without the disorder. - New Psychiatric Program at The Mount Sinai Medical Center Addresses Special Needs of Multiple Sclerosis Patients - February 26, 2009
The new program provides for an on-site psychiatrist to assist in the identification and management of psychiatric and psychological disorders in patients with MS, including depression. - Gene Mutations Identified As Cause of Primary Torsion Dystonia - February 3, 2009
Mount Sinai researchers have identified mutations in gene THAP1 as a cause of primary torsion dystonia. The discovery may lead to new treatments for this debilitating disease.